Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
about
Mechanism and significance of cell type-dependent neutralization of flavivirusesShake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostLocalization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive EpitopesStructure of yellow fever virus envelope protein domain IIIQuantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrinAn in-depth analysis of original antigenic sin in dengue virus infectionProteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)The Cellular Bases of Antibody Responses during Dengue Virus InfectionAntibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E ProteinThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesDissecting the cell entry pathway of dengue virus by single-particle tracking in living cellsDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusSystematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM ProteinRecovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse VirulenceHeat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cellsNeuroblastoma Cell-Adapted Yellow Fever 17D Virus: Characterization of a Viral Variant Associated with Persistent Infection and Decreased Virus SpreadIdentification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.Development of a humanized monoclonal antibody with therapeutic potential against West Nile virusStructures of immature flavivirus particlesPathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral EvasionA ligand-binding pocket in the dengue virus envelope glycoproteinAntibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinAntiviral Peptides Targeting the West Nile Virus Envelope ProteinTwo Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus SerotypesAn adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypesPreparation and immunogenic properties of a recombinant West Nile subunit vaccineFunctional Requirements of the Yellow Fever Virus Capsid ProteinSolution structure of the envelope protein domain III of dengue-4 virusRefolding, crystallization and preliminary X-ray structural studies of the West Nile virus envelope (E) protein domain IIIDifferentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-ReactivityPediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue VirusSingle Antigen Detects both Immunoglobulin M (IgM) and IgG Antibodies Elicited by All Four Dengue Virus SerotypesCharacterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking.Induction of Epitope-Specific Neutralizing Antibodies against West Nile VirusEpitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized AntibodyType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesNMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognitionGenetically delivered antibody protects against West Nile virusMonoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and Vaccines
P2860
Q23032973-F2AB1C11-F83D-4C42-A37C-8B2B5867D6A1Q23925011-951901AC-5C95-4FD5-8957-212A0B9107A4Q24289053-2B80F83F-5C0B-4999-A967-728EF900F7F0Q24289393-29E2A231-851A-4E62-8680-64BDA53E6CBAQ24294153-15442E78-6C24-4DCF-9BBD-5012115980D8Q24606493-0BB82F16-4BE3-4A4C-8B0D-6F257CAFB0EDQ24800750-13DA8F18-ECD6-4617-B8AF-878EE90E4D52Q26700056-BDB6B9CF-DBB3-42EA-91D6-958FCFC76D70Q26700124-224DC98C-BA44-4824-BEB1-6CF1DF66AF06Q26995782-CEC040B9-7EEA-4975-8846-C08F65B89F43Q27304342-9103519D-7D8E-4B8B-B892-FF67A3D80C06Q27318246-F5B10E41-F49B-4081-B38C-DB4144C2211AQ27335008-A14119FB-139A-4869-B888-8FD96723E038Q27468788-42783313-70A2-408F-A2A2-022B2ED6ECEDQ27469118-727D8FF5-4A0E-479A-A93C-F9400012156CQ27469442-A8B5C25B-4F63-4A92-A75F-A1353B48BF45Q27472880-B84E607B-7CAC-4AEF-8A70-FCA268A3CBFFQ27472922-04E80287-3B65-490C-ABC2-269D24BF9E92Q27473186-6F0330AF-0386-4D2F-B425-D397C4FBCB14Q27477478-E942C7BE-59F6-49A5-9BF1-CD8E4DD414AEQ27477543-7DFC159C-FDDD-41B7-82DC-33D456EE4A2FQ27477685-2109782C-A921-42D7-A592-550BD0264C3DQ27477718-1A6D965A-FED6-4B2B-87C0-B625D986955AQ27478055-21BFD9E4-71C6-4903-8196-D94A5D4192C0Q27478075-6C380FBA-B79A-4EA5-B98F-162F1BA9C142Q27478104-CE954C50-67FC-4AF1-A05F-5A2E16E294A6Q27478202-10DB64F4-1713-4058-A209-A3119292A30DQ27480340-0587B522-9FDF-4A57-8197-C82A2BD1415CQ27480990-32A97ADD-2CA2-4CC1-980D-789E37865706Q27481038-6E01FBE3-9EDF-4694-B9C0-0206E510F962Q27481450-56D9BB33-8EEB-46DE-8346-8767BDD2C2EEQ27484362-FEECE546-C5A1-4596-9EF5-4AC516B5F4E9Q27484622-8700F1C7-6B21-4AA8-82FB-30FB981680D2Q27484978-3532F251-92B1-4A8A-B4CD-083E8E3BCBFFQ27484980-555BF497-2C4B-4102-B0E2-05E7234C2791Q27485025-2E89E7A5-8666-4C97-A249-E14986BD18DDQ27485031-12C07B23-E23A-4469-80B8-55B151D34E9BQ27485383-5DFD3F6B-F5DD-40B2-9C30-594A04F3676DQ27485481-83EEAB2F-4FB9-4731-8D4E-7A30DB6829FAQ27485490-90A259B5-7D14-4151-9B58-557013FF6BB8
P2860
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@ast
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@en
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@nl
type
label
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@ast
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@en
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@nl
prefLabel
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@ast
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@en
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@nl
P2860
P3181
P1433
P1476
Monoclonal Antibodies That Bin ...... Virus Adsorption to Vero Cells
@en
P2093
P2860
P304
P3181
P356
10.1128/JVI.75.16.7769-7773.2001
P50
P577
2001-08-01T00:00:00Z